Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 13/20 | 0.42 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.42 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5134308 | 0.83 | BACE1 (0.43) | BACE1BACE2CTSD | |
| SCHEMBL4525769 | 0.82 | BACE1 (0.35) | BACE1 | |
| Hydrochloric Acid SCHEMBL5137186 | 0.79 | BACE1 (0.38) | BACE1BACE2CTSD | |
| SCHEMBL4509201 | 0.75 | BACE1 (0.71) | BACE1BACE2CTSD | |
| SCHEMBL4781470 | 0.72 | BACE1 (0.40) | BACE1BACE2CTSDBRD4 | |
| SCHEMBL4848219 | 0.71 | CA12 (0.35) | BACE1BACE2CTSD | |
| SCHEMBL5134481 | 0.70 | BACE1 (0.40) | BACE1BACE2CTSD | |
| SCHEMBL5134703 | 0.70 | FFAR1 (0.36) | BACE1BACE2CTSD | |
| SCHEMBL4787010 | 0.69 | BACE1 (0.36) | BACE1BACE2CTSD | |
| SCHEMBL4525146 | 0.68 | BACE1 (0.42) | BACE1BACE2CTSDBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1979324-A2 | NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA | Astra Zeneca AB (SE) | 2008-10-15 | — | — | EP | claimed |
| WO-2007058602-A2 | NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, NEURODEGENERATION AND DEMENTIA. | ASTRAZENECA AB (SE) | 2007-05-24 | — | — | WO | claimed |